Cara Edwards > DLA Piper LLP (US) > New York, United States > Lawyer Profile

DLA Piper LLP (US)
NEW YORK, NY 10020-1104
United States
Cara Edwards photo

Work Department

Litigation, Arbitration and Investigations; Product Liability, Mass Torts and Product Stewardship;  Life Sciences




Cara Edwards is a partner in DLA Piper’s Product Liability and Mass Tort practice group. Cara has a diverse range of experience representing and advising global pharmaceutical, medical device, and consumer goods clients in a variety of product liability and commercial litigation matters, with an emphasis on serving as national counsel in complex, multi-jurisdictional product liability suits in state and federal courts.

Cara provides strategic advice at every stage of litigation, beginning with proactive risk assessments before medications and devices are approved, and continuing through pretrial discovery, expert development and strategy, dispositive motion practice, bellwether trials, appeals, and ultimately, resolution. Her experience also includes regularly counselling clients on a wide range of risk management, regulatory, clinical research and development, product labeling, recall and public disclosure issues.

Cara’s practice involves matters with cross-border aspects and international parties. She has experience litigating cases outside the U.S. for her global clients, and offering counselling regarding foreign healthcare authorities.

Cara is the Deputy Managing Partner of the New York Office.


DRI (Defense Research Institute); Association of Black Women Attorneys; National Association of Women Lawyers


J.D., New York University; B.A., Colgate University

Lawyer Rankings

United States > Dispute resolution > Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

Within: Next Generation Partners -

Cara Edwards

DLA Piper LLP (US)

DLA Piper LLP (US) is headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and is one of the leading firms for high-profile product liability litigation and mass torts in the medical and pharmaceuticals sectors. Notable highlights include representing Medtronic and Covidien as co-national counsel in the hernia mesh litigation, and defending Pfizer and Wyeth Pharmaceuticals in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. In other work, the highly regarded Loren Brown in New York is acting for Pfizer alongside Boston-based Matthew Holian in an MDL involving claims that anti-coagulant medication Eliquis causes bleeding. Cara Edwards in New York is also recommended. In January 2018, the team welcomed Stephen Matthews and Amy Rubenstein from Porzio, Bromberg & Newman and Schiff Hardin LLP respectively; in February 2018, Matt Nickel and Mike Moore joined from Dentons.